Global and Europe Immune system drugs Market - Analysis and Outlook to 2022

Published: Aug, 2017 | Pages: 132 | Publisher: EU Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report presents a comprehensive overview of the Immune system drugs market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Immune system drugs industry.

This report focuses Global and Europe market, including details as following:

Key Players
AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai
AbbVie Inc. US 60064 North Chicago
ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara
APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore
BIOCON LIMITED IN 560 100 Bangalore
CF PHARMA LTD. HU 1097 Budapest
CIPLA LIMITED IN 400 013 Mumbai
CKD BIO CORPORATION KR 15604 Ansan-si
CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad
EMCURE PHARMACEUTICALS LIMITED IN 411 026 Pune
EUTICALS S.P.A. IT 20089 Rozzano
EXCELLA GMBH & CO. KG DE 90537 Feucht
Fermion Oy FI 02200 Espoo
Fine Chemicals Corporation (Pty) Ltd. ZA 7460 Cape Town
FORMOSA LABORATORIES, INC. TW 33842 Taoyuan
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. CN 310 011 Hangzhou
HETERO LABS LIMITED IN 500 018 Hyderabad
Hisun Pharmaceutical (Hangzhou) Co., Ltd. CN 311 404 Hangzhou City
HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. CN 313 018 Linghu Town
LEK PHARMACEUTICALS D.D. SI 1526 Ljubljana
Medigraph Pharmaceuticals Pvt. Ltd. IN 400071 Mumbai
Microbiologica Quimica e Farmaceutica Ltda BR 20765-120 Rio De Janeiro
RPG Life Sciences Limited IN 400 703 Navi Mumbai
SICOR S.R.L. IT 20017 Rho
TAISHAN CITY CHEMICAL PHARMACEUTICAL CO., LTD. CN 529 200 Taishan City
TEVA CZECH INDUSTRIES S.R.O. CZ 747 70 Opava-Komarov
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. CN 325 700 Dong Ping

Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Key Product Type
Immune system drugs Market, by Immunosuppressive drugs
Azathioprine
Tripterygium Glycosides
Cyclosporine
Sandimmune
Ciclosporin
Cyclosporine
Neoral
Tacrolimus
Rapamycin
Mycophenolate
Everolimus
Diacerein
Mizoribine
Gusperimus
Etanercept
Muromonab-CD3
Cyclophosphamide
Fingolimod
Leflunomide
Imiquimod
Chloroquinum
Methotrexate
Immune system drugs Market, by Immunoregulants
Inosine pranobex
Melotonin
Killer helper factor,KHF
Thymopentin
Interleukin
?-globulin
Interferon
Ubenimex
Pidotimod
Thymopentin

Key Applications
Internal Medicine
Department of surgery
Infections Department
Hospital

 Table of Contents

Global and Europe Immune system drugs Market - Analysis and Outlook to 2022
1 Market Outline
    1.1 Research Methodology
        1.1.1 Methodology/Research Approach
            Research Programs/Design
            Market Size Estimation
            Market Breakdown and Data Triangulation
        1.1.2 Data Source
            Secondary Sources
            Primary Sources
        1.1.3 Disclaimer
    1.2 Regulatory Factors
    1.3 End-User Analysis
    1.4 Strategic Benchmarking
    1.5 Industry Chain and Supply Chain
        1.5.1 Immune system drugs Industry Chain Structure
            1.5.1.1 R&D
            1.5.1.2 Raw Materials (Components)
            1.5.1.3 Manufacturing Plants
            1.5.1.4 Regional Trading (Import Export and Local Sales)
            1.5.1.5 Online Sales Channel
            1.5.1.6 Offline Channel
            1.5.1.7 End Users
        1.5.2 Immune system drugs Manufacturing
            1.5.2.1 Key Components
            1.5.2.2 Assembly Manufacturing
        1.5.3 Consumer Preference
        1.5.4 Behavioral Habits
        1.5.5 Marketing Environment
    1.6 SWOT Analysis
    1.7 Feasibility Analysis
    1.8 Development Trend and Research Conclusion
        1.8.1 Development Trend
        1.8.2 Research Conclusion

2 Global Immune system drugs Product Overview
    2.1 Global Immune system drugs Market Sales Volume Revenue and Price 2012-2017
    2.2 Immune system drugs, by Immunosuppressive drugs 2012-2017
        2.2.1 Global Immune system drugs Sales Market Share by Immunosuppressive drugs 2012-2017
        2.2.2 Global Immune system drugs Revenue Market Share by Immunosuppressive drugs 2012-2017
        2.2.3 Global Immune system drugs Price by Immunosuppressive drugs 2012-2017
        2.2.4 Azathioprine
        2.2.5 Tripterygium Glycosides
        2.2.6 Cyclosporine
        2.2.7 Sandimmune
        2.2.8 Ciclosporin
              Cyclosporine
              Neoral
              Tacrolimus
              Rapamycin
              Mycophenolate
              Everolimus
              Diacerein
              Mizoribine
              Gusperimus
              Etanercept
              Muromonab-CD3
              Cyclophosphamide
              Fingolimod
              Leflunomide
              Imiquimod
              Chloroquinum
              Methotrexate
    2.3 Immune system drugs, by Immunoregulants 2012-2017
        2.3.1 Global Immune system drugs Sales Market Share by Immunoregulants 2012-2017
        2.3.2 Global Immune system drugs Revenue Market Share by Immunoregulants 2012-2017
        2.3.3 Global Immune system drugs Price by Immunoregulants 2012-2017
        2.3.4 Inosine pranobex
        2.3.5 Melotonin
        2.3.6 Killer helper factor,KHF
        2.3.7 Thymopentin
        2.3.8 Interleukin
              ?-globulin
              Interferon
              Ubenimex 
              Pidotimod
              Thymopentin

3 Europe Immune system drugs Product Overview
    3.1 Europe Immune system drugs Market Sales Volume Revenue and Price 2012-2017
    3.2 Immune system drugs, by Immunosuppressive drugs 2012-2017
        3.2.1 Europe Immune system drugs Sales Market Share by Immunosuppressive drugs 2012-2017
        3.2.2 Europe Immune system drugs Revenue Market Share by Immunosuppressive drugs 2012-2017
        3.2.3 Europe Immune system drugs Price by Immunosuppressive drugs 2012-2017
        3.2.4 Azathioprine
        3.2.5 Tripterygium Glycosides
        3.2.6 Cyclosporine
        3.2.7 Sandimmune
        3.2.8 Ciclosporin
              Cyclosporine
              Neoral
              Tacrolimus
              Rapamycin
              Mycophenolate
              Everolimus
              Diacerein
              Mizoribine
              Gusperimus
              Etanercept
              Muromonab-CD3
              Cyclophosphamide
              Fingolimod
              Leflunomide
              Imiquimod
              Chloroquinum
              Methotrexate
    3.3 Immune system drugs, by Immunoregulants 2012-2017
        3.3.1 Europe Immune system drugs Sales Market Share by Immunoregulants 2012-2017
        3.3.2 Europe Immune system drugs Revenue Market Share by Immunoregulants 2012-2017
        3.3.3 Europe Immune system drugs Price by Immunoregulants 2012-2017
        3.3.4 Inosine pranobex
        3.3.5 Melotonin
        3.3.6 Killer helper factor,KHF
        3.3.7 Thymopentin
        3.3.8 Interleukin
              ?-globulin
              Interferon
              Ubenimex 
              Pidotimod
              Thymopentin

4 Immune system drugs Top Companies Profile
    4.1 AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai
        4.1.1 AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Company Details and Competitors
        4.1.2 AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Key Immune system drugs Models and Performance
        4.1.3 AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Business SWOT Analysis and Forecast
        4.1.4 AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.2 AbbVie Inc. US 60064 North Chicago
        4.2.1 AbbVie Inc. US 60064 North Chicago Company Details and Competitors
        4.2.2 AbbVie Inc. US 60064 North Chicago Key Immune system drugs Models and Performance
        4.2.3 AbbVie Inc. US 60064 North Chicago Immune system drugs Business SWOT Analysis and Forecast
        4.2.4 AbbVie Inc. US 60064 North Chicago Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
        4.3.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
        4.3.2 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Immune system drugs Models and Performance
        4.3.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Business SWOT Analysis and Forecast
        4.3.4 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.4 AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara
        4.4.1 AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Company Details and Competitors
        4.4.2 AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Key Immune system drugs Models and Performance
        4.4.3 AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Business SWOT Analysis and Forecast
        4.4.4 AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.5 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore
        4.5.1 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Company Details and Competitors
        4.5.2 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Key Immune system drugs Models and Performance
        4.5.3 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Business SWOT Analysis and Forecast
        4.5.4 APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.6 BIOCON LIMITED IN 560 100 Bangalore
        4.6.1 BIOCON LIMITED IN 560 100 Bangalore Company Details and Competitors
        4.6.2 BIOCON LIMITED IN 560 100 Bangalore Key Immune system drugs Models and Performance
        4.6.3 BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Business SWOT Analysis and Forecast
        4.6.4 BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.7 CF PHARMA LTD. HU 1097 Budapest
        4.7.1 CF PHARMA LTD. HU 1097 Budapest Company Details and Competitors
        4.7.2 CF PHARMA LTD. HU 1097 Budapest Key Immune system drugs Models and Performance
        4.7.3 CF PHARMA LTD. HU 1097 Budapest Immune system drugs Business SWOT Analysis and Forecast
        4.7.4 CF PHARMA LTD. HU 1097 Budapest Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.8 CIPLA LIMITED IN 400 013 Mumbai
        4.8.1 CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
        4.8.2 CIPLA LIMITED IN 400 013 Mumbai Key Immune system drugs Models and Performance
        4.8.3 CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Business SWOT Analysis and Forecast
        4.8.4 CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.9 CKD BIO CORPORATION KR 15604 Ansan-si
        4.9.1 CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
        4.9.2 CKD BIO CORPORATION KR 15604 Ansan-si Key Immune system drugs Models and Performance
        4.9.3 CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Business SWOT Analysis and Forecast
        4.9.4 CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.10 CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad
        4.10.1 CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Company Details and Competitors
        4.10.2 CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Key Immune system drugs Models and Performance
        4.10.3 CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Business SWOT Analysis and Forecast
        4.10.4 CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    4.11 EMCURE PHARMACEUTICALS LIMITED IN 411 026 Pune
    4.12 EUTICALS S.P.A. IT 20089 Rozzano
    4.13 EXCELLA GMBH & CO. KG DE 90537 Feucht
    4.14 Fermion Oy FI 02200 Espoo
    4.15 Fine Chemicals Corporation (Pty) Ltd. ZA 7460 Cape Town
    4.16 FORMOSA LABORATORIES, INC. TW 33842 Taoyuan
    4.17 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. CN 310 011 Hangzhou
    4.18 HETERO LABS LIMITED IN 500 018 Hyderabad
    4.19 Hisun Pharmaceutical (Hangzhou) Co., Ltd. CN 311 404 Hangzhou City
    4.20 HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. CN 313 018 Linghu Town
    4.21 LEK PHARMACEUTICALS D.D. SI 1526 Ljubljana
    4.22 Medigraph Pharmaceuticals Pvt. Ltd. IN 400071 Mumbai
    4.23 Microbiologica Quimica e Farmacêutica Ltda BR 20765-120 Rio De Janeiro
    4.24 RPG Life Sciences Limited IN 400 703 Navi Mumbai
    4.25 SICOR S.R.L. IT 20017 Rho
    4.26 TAISHAN CITY CHEMICAL PHARMACEUTICAL CO., LTD. CN 529 200 Taishan City
    4.27 TEVA CZECH INDUSTRIES S.R.O. CZ 747 70 Opava-Komarov
    4.28 Zhejiang Cheng Yi Pharmaceutical Co., Ltd. CN 325 700 Dong Ping

5 Immune system drugs by Regions 2012-2017
    5.1 Global Immune system drugs Sales Market Share by Regions 2012-2017
    5.2 Global Immune system drugs Revenue Market Share by Regions 2012-2017
    5.3 Global Immune system drugs Price by Regions 2012-2017
    5.4 North America
        5.4.1 United States
        5.4.2 Canada
    5.5 Latin America
        5.5.1 Mexico
        5.5.2 Brazil
        5.5.3 Argentina
        5.5.4 Others in Latin America
    5.6 Europe
        5.6.1 Germany
        5.6.2 United Kingdom
        5.6.3 France
        5.6.4 Italy
        5.6.5 Spain
        5.6.6 Russia
        5.6.7 Netherland
        5.6.8 Others in Europe
    5.7 Asia & Pacific
        5.7.1 China
        5.7.2 Japan
        5.7.3 India
        5.7.4 Korea
        5.7.5 Australia
        5.7.6 Southeast Asia
            5.7.6.1 Indonesia
            5.7.6.2 Thailand
            5.7.6.3 Philippines
            5.7.6.4 Vietnam
            5.7.6.5 Singapore
            5.7.6.6 Malaysia
            5.7.6.7 Others in Southeast Asia
    5.8 Africa & Middle East
        5.8.1 South Africa
        5.8.2 Egypt
        5.8.3 Turkey
        5.8.4 Saudi Arabia
        5.8.5 Iran
        5.8.6 Others in Africa & Middle East

6 GlobalImmune system drugs by Players 2012-2017
    6.1 Global Immune system drugs Sales Volume Market Share by Brands 2012-2017
    6.2 Global Immune system drugs Revenue Share by Brands 2012-2017
    6.3 Global Top Players Immune system drugs Key Product Model and Market Performance
    6.4 Global Top Players Immune system drugs Key Target Consumers and Market Performance

7 EuropeImmune system drugs by Players 2012-2017
    7.1 Europe Immune system drugs Sales Volume Market Share by Brands 2012-2017
    7.2 Europe Immune system drugs Revenue Share by Brands 2012-2017
    7.3 Europe Top Players Immune system drugs Key Product Model and Market Performance
    7.4 Europe Top Players Immune system drugs Key Target Consumers and Market Performance

8 Global Immune system drugs by Consumer 2012-2017
    8.1 Global Immune system drugs Sales Market Share by Consumer 2012-2017
    8.2 Internal Medicine
    8.3 Department of surgery
    8.4 Infections Department
    8.5 Hospital
    8.6 Consuming Habit and Preference

9 Europe Immune system drugs by Consumer 2012-2017
    9.1 Europe Immune system drugs Sales Market Share by Consumer 2012-2017
    9.2 Internal Medicine
    9.3 Department of surgery
    9.4 Infections Department
    9.5 Hospital
    9.6 Consuming Habit and Preference

10 Global Immune system drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Immune system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Immune system drugs Sales () Forecast by Regions (2017-2022)
    10.3 Global Immune system drugs Sales () Forecast by Application (2017-2022)
    10.4 Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    10.5 Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)

11 Europe Immune system drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 Europe Immune system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 Europe Immune system drugs Sales () Forecast by Regions (2017-2022)
    11.3 Europe Immune system drugs Sales () Forecast by Application (2017-2022)
    11.4 Europe Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    11.5 Europe Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)

List of Tables and Figures

    Table Global Immune system drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Immune system drugs Sales Volume () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales () by Immunosuppressive drugs (2012-2017)
    Table Global Immune system drugs Sales Market Share by Immunosuppressive drugs (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Immunosuppressive drugs in 2016
    Table Global Immune system drugs Revenue (Million USD) by Immunosuppressive drugs (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Immunosuppressive drugs (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Immunosuppressive drugs in 2016
    Table Global Immune system drugs Price () by Immunosuppressive drugs (2012-2017)
    Table Top Players of Azathioprine Immune system drugs Products List
    Figure Global Azathioprine Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Tripterygium Glycosides Immune system drugs Products List
    Figure Global Tripterygium Glycosides Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Cyclosporine Immune system drugs Products List
    Figure Global Cyclosporine Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Sandimmune Immune system drugs Products List
    Figure Global Sandimmune Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Ciclosporin Immune system drugs Products List
    Figure Global Ciclosporin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales () by Immunoregulants (2012-2017)
    Table Global Immune system drugs Sales Market Share by Immunoregulants (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Immunoregulants in 2016
    Table Global Immune system drugs Revenue (Million USD) by Immunoregulants (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Immunoregulants (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Immunoregulants in 2016
    Table Global Immune system drugs Price () by Immunoregulants (2012-2017)
    Table Top Players of Inosine pranobex Immune system drugs Products List
    Figure Global Inosine pranobex Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Melotonin Immune system drugs Products List
    Figure Global Melotonin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Killer helper factor,KHF Immune system drugs Products List
    Figure Global Killer helper factor,KHF Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Thymopentin Immune system drugs Products List
    Figure Global Thymopentin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Interleukin Immune system drugs Products List
    Figure Global Interleukin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales () by  (2012-2017)
    Table Global Immune system drugs Sales Market Share by  (2012-2017)
    Figure Global Immune system drugs Sales Market Share by  in 2016
    Table Global Immune system drugs Revenue (Million USD) by  (2012-2017)
    Table Global Immune system drugs Revenue Market Share by  (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by  in 2016
    Table Global Immune system drugs Price () by  (2012-2017)
    Table Global Immune system drugs Sales () by  (2012-2017)
    Table Global Immune system drugs Sales Market Share by  (2012-2017)
    Figure Global Immune system drugs Sales Market Share by  in 2016
    Table Global Immune system drugs Revenue (Million USD) by  (2012-2017)
    Table Global Immune system drugs Revenue Market Share by  (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by  in 2016
    Table Global Immune system drugs Price () by  (2012-2017)
    Table Europe Immune system drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Europe Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Immune system drugs Sales Volume () and Growth Rate (2012-2017)
    Table Europe Immune system drugs Sales () by Immunosuppressive drugs (2012-2017)
    Table Europe Immune system drugs Sales Market Share by Immunosuppressive drugs (2012-2017)
    Figure Europe Immune system drugs Sales Market Share by Immunosuppressive drugs in 2016
    Table Europe Immune system drugs Revenue (Million USD) by Immunosuppressive drugs (2012-2017)
    Table Europe Immune system drugs Revenue Market Share by Immunosuppressive drugs (2012-2017)
    Figure Europe Immune system drugs Revenue Market Share by Immunosuppressive drugs in 2016
    Table Europe Immune system drugs Price () by Immunosuppressive drugs (2012-2017)
    Table Top Players of Azathioprine Immune system drugs Products List
    Figure Europe Azathioprine Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Tripterygium Glycosides Immune system drugs Products List
    Figure Europe Tripterygium Glycosides Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Cyclosporine Immune system drugs Products List
    Figure Europe Cyclosporine Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Sandimmune Immune system drugs Products List
    Figure Europe Sandimmune Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Ciclosporin Immune system drugs Products List
    Figure Europe Ciclosporin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Europe Immune system drugs Sales () by Immunoregulants (2012-2017)
    Table Europe Immune system drugs Sales Market Share by Immunoregulants (2012-2017)
    Figure Europe Immune system drugs Sales Market Share by Immunoregulants in 2016
    Table Europe Immune system drugs Revenue (Million USD) by Immunoregulants (2012-2017)
    Table Europe Immune system drugs Revenue Market Share by Immunoregulants (2012-2017)
    Figure Europe Immune system drugs Revenue Market Share by Immunoregulants in 2016
    Table Europe Immune system drugs Price () by Immunoregulants (2012-2017)
    Table Top Players of Inosine pranobex Immune system drugs Products List
    Figure Europe Inosine pranobex Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Melotonin Immune system drugs Products List
    Figure Europe Melotonin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Killer helper factor,KHF Immune system drugs Products List
    Figure Europe Killer helper factor,KHF Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Thymopentin Immune system drugs Products List
    Figure Europe Thymopentin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Interleukin Immune system drugs Products List
    Figure Europe Interleukin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Europe Immune system drugs Sales () by  (2012-2017)
    Table Europe Immune system drugs Sales Market Share by  (2012-2017)
    Figure Europe Immune system drugs Sales Market Share by  in 2016
    Table Europe Immune system drugs Revenue (Million USD) by  (2012-2017)
    Table Europe Immune system drugs Revenue Market Share by  (2012-2017)
    Figure Europe Immune system drugs Revenue Market Share by  in 2016
    Table Europe Immune system drugs Price () by  (2012-2017)
    Table Europe Immune system drugs Sales () by  (2012-2017)
    Table Europe Immune system drugs Sales Market Share by  (2012-2017)
    Figure Europe Immune system drugs Sales Market Share by  in 2016
    Table Europe Immune system drugs Revenue (Million USD) by  (2012-2017)
    Table Europe Immune system drugs Revenue Market Share by  (2012-2017)
    Figure Europe Immune system drugs Revenue Market Share by  in 2016
    Table Europe Immune system drugs Price () by  (2012-2017)
    Table AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Company Details and Competitors
    Table AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Key Immune system drugs Models and Performance
    Table AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Business SWOT Analysis and Forecast
    Table AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AARTI INDUSTRIES LIMITED IN 400 080 Mulund (W), Mumbai Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AbbVie Inc. US 60064 North Chicago Company Details and Competitors
    Table AbbVie Inc. US 60064 North Chicago Key Immune system drugs Models and Performance
    Table AbbVie Inc. US 60064 North Chicago Immune system drugs Business SWOT Analysis and Forecast
    Table AbbVie Inc. US 60064 North Chicago Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AbbVie Inc. US 60064 North Chicago Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AbbVie Inc. US 60064 North Chicago Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AbbVie Inc. US 60064 North Chicago Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AbbVie Inc. US 60064 North Chicago Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Company Details and Competitors
    Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Key Immune system drugs Models and Performance
    Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Business SWOT Analysis and Forecast
    Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Company Details and Competitors
    Table AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Key Immune system drugs Models and Performance
    Table AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Business SWOT Analysis and Forecast
    Table AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AMI LIFESCIENCES PRIVATE LIMITED IN 390 020 Vadodara Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Company Details and Competitors
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Key Immune system drugs Models and Performance
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Business SWOT Analysis and Forecast
    Table APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure APOTEX PHARMACHEM INDIA PVT. LTD IN 560 099 Bangalore Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table BIOCON LIMITED IN 560 100 Bangalore Company Details and Competitors
    Table BIOCON LIMITED IN 560 100 Bangalore Key Immune system drugs Models and Performance
    Table BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Business SWOT Analysis and Forecast
    Table BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BIOCON LIMITED IN 560 100 Bangalore Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table CF PHARMA LTD. HU 1097 Budapest Company Details and Competitors
    Table CF PHARMA LTD. HU 1097 Budapest Key Immune system drugs Models and Performance
    Table CF PHARMA LTD. HU 1097 Budapest Immune system drugs Business SWOT Analysis and Forecast
    Table CF PHARMA LTD. HU 1097 Budapest Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CF PHARMA LTD. HU 1097 Budapest Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CF PHARMA LTD. HU 1097 Budapest Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure CF PHARMA LTD. HU 1097 Budapest Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CF PHARMA LTD. HU 1097 Budapest Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table CIPLA LIMITED IN 400 013 Mumbai Company Details and Competitors
    Table CIPLA LIMITED IN 400 013 Mumbai Key Immune system drugs Models and Performance
    Table CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Business SWOT Analysis and Forecast
    Table CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CIPLA LIMITED IN 400 013 Mumbai Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table CKD BIO CORPORATION KR 15604 Ansan-si Company Details and Competitors
    Table CKD BIO CORPORATION KR 15604 Ansan-si Key Immune system drugs Models and Performance
    Table CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Business SWOT Analysis and Forecast
    Table CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CKD BIO CORPORATION KR 15604 Ansan-si Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Company Details and Competitors
    Table CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Key Immune system drugs Models and Performance
    Table CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Business SWOT Analysis and Forecast
    Table CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CONCORD BIOTECH LIMITED IN 380 015 Ahmedabad Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table EMCURE PHARMACEUTICALS LIMITED IN 411 026 Pune Company Details and Competitors
    Table EUTICALS S.P.A. IT 20089 Rozzano Company Details and Competitors
    Table EXCELLA GMBH & CO. KG DE 90537 Feucht Company Details and Competitors
    Table Fermion Oy FI 02200 Espoo Company Details and Competitors
    Table Fine Chemicals Corporation (Pty) Ltd. ZA 7460 Cape Town Company Details and Competitors
    Table FORMOSA LABORATORIES, INC. TW 33842 Taoyuan Company Details and Competitors
    Table Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. CN 310 011 Hangzhou Company Details and Competitors
    Table HETERO LABS LIMITED IN 500 018 Hyderabad Company Details and Competitors
    Table Hisun Pharmaceutical (Hangzhou) Co., Ltd. CN 311 404 Hangzhou City Company Details and Competitors
    Table HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. CN 313 018 Linghu Town Company Details and Competitors
    Table LEK PHARMACEUTICALS D.D. SI 1526 Ljubljana Company Details and Competitors
    Table Medigraph Pharmaceuticals Pvt. Ltd. IN 400071 Mumbai Company Details and Competitors
    Table Microbiologica Quimica e Farmacêutica Ltda BR 20765-120 Rio De Janeiro Company Details and Competitors
    Table RPG Life Sciences Limited IN 400 703 Navi Mumbai Company Details and Competitors
    Table SICOR S.R.L. IT 20017 Rho Company Details and Competitors
    Table TAISHAN CITY CHEMICAL PHARMACEUTICAL CO., LTD. CN 529 200 Taishan City Company Details and Competitors
    Table TEVA CZECH INDUSTRIES S.R.O. CZ 747 70 Opava-Komarov Company Details and Competitors
    Table Zhejiang Cheng Yi Pharmaceutical Co., Ltd. CN 325 700 Dong Ping Company Details and Competitors
    Table Global Immune system drugs Sales () by Regions (2012-2017)
    Table Global Immune system drugs Sales Share by Regions (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Regions in 2016
    Figure Global Immune system drugs Sales Market Share by Regions in 2017
    Table Global Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Regions (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Regions in 2016
    Figure Global Immune system drugs Revenue Market Share by Regions in 2017
    Table Global Immune system drugs Price () by Regions (2012-2017)
    Table North America Immune system drugs Sales () by Regions (2012-2017)
    Table North America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Figure North America Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Latin America Immune system drugs Sales () by Regions (2012-2017)
    Table Latin America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Europe Immune system drugs Sales () by Regions (2012-2017)
    Table Europe Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Immune system drugs Sales () by Regions (2012-2017)
    Table Asia & Pacific Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Immune system drugs Sales () by Regions (2012-2017)
    Table Africa & Middle East Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales Volume () by Key Players 2012-2017
    Table Global Immune system drugs Sales Volume Market Share by Key Players 2012-2017
    Figure Global Immune system drugs Sales Volume Market Share by Key Players 2016
    Figure Global Immune system drugs Sales Volume Market Share by Key Players 2017
    Table Global Immune system drugs Revenue (Million USD) by Key Players 2012-2017
    Table Global Immune system drugs Revenue Market Share by Key Players 2012-2017
    Figure Global Immune system drugs Revenue Market Share by Key Players 2016
    Figure Global Immune system drugs Revenue Market Share by Key Players 2017
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Europe Immune system drugs Sales Volume () by Key Players 2012-2017
    Table Europe Immune system drugs Sales Volume Market Share by Key Players 2012-2017
    Figure Europe Immune system drugs Sales Volume Market Share by Key Players 2016
    Figure Europe Immune system drugs Sales Volume Market Share by Key Players 2017
    Table Europe Immune system drugs Revenue (Million USD) by Key Players 2012-2017
    Table Europe Immune system drugs Revenue Market Share by Key Players 2012-2017
    Figure Europe Immune system drugs Revenue Market Share by Key Players 2016
    Figure Europe Immune system drugs Revenue Market Share by Key Players 2017
    Table Europe Top Players Key Product Model and Market Performance
    Table Europe Top Players Key Target Consumers and Market Performance
    Table Global Immune system drugs Sales () by Consumer (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Consumer (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Consumer in 2016
    Figure Global Internal Medicine Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Department of surgery Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Infections Department Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Hospital Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Europe Immune system drugs Sales () by Consumer (2012-2017)
    Figure Europe Immune system drugs Sales Market Share by Consumer (2012-2017)
    Figure Europe Immune system drugs Sales Market Share by Consumer in 2016
    Figure Europe Internal Medicine Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Europe Department of surgery Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Europe Infections Department Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Europe Hospital Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Immune system drugs Price () Trend Forecast (2017-2022)
    Table Global Immune system drugs Sales () Forecast by Regions (2017-2022)
    Table Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Immune system drugs Sales Volume Share Forecast by Regions in 2022
    Table Global Immune system drugs Sales () Forecast by Application (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Application in 2022
    Table Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    Figure Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunosuppressive drugs in 2022
    Table Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
    Figure Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunoregulants in 2022
    Figure Europe Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Europe Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Europe Immune system drugs Price () Trend Forecast (2017-2022)
    Table Europe Immune system drugs Sales () Forecast by Regions (2017-2022)
    Table Europe Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Immune system drugs Sales Volume Share Forecast by Regions in 2022
    Table Europe Immune system drugs Sales () Forecast by Application (2017-2022)
    Figure Europe Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Europe Immune system drugs Sales Volume Market Share Forecast by Application in 2022
    Table Europe Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    Figure Europe Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    Figure Europe Immune system drugs Sales Volume Market Share Forecast by Immunosuppressive drugs in 2022
    Table Europe Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
    Figure Europe Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
    Figure Europe Immune system drugs Sales Volume Market Share Forecast by Immunoregulants in 2022